120
Participants
Start Date
September 28, 2020
Primary Completion Date
July 8, 2021
Study Completion Date
August 18, 2021
KX-826-2.5 mg (0.25%)/60 mL BID
Topical application, 7 sprays (approximately 1 mL)/time, in the target area of the scalp (8 cm × 8 cm), starting from the center of the affected area, and massage with hands for 3-5 min. This dose is used regardless of the size of the affected area. It should be used when hair and scalp are completely dry. Wash hands after use. The control product will be administered once in the morning and once in the evening.
KX-826-5 mg (5%)/60 mL QD
Topical application, 7 sprays (approximately 1 mL)/time, in the target area of the scalp (8 cm × 8 cm), starting from the center of the affected area, and massage with hands for 3-5 min. This dose is used regardless of the size of the affected area. It should be used when hair and scalp are completely dry. Wash hands after use. The control product will be administered in the evening once daily.
KX-826-5 mg (5%)/60 mL BID
Topical application, 7 sprays (approximately 1 mL)/time, in the target area of the scalp (8 cm × 8 cm), starting from the center of the affected area, and massage with hands for 3-5 min. This dose is used regardless of the size of the affected area. It should be used when hair and scalp are completely dry. Wash hands after use. The control product will be administered once in the morning and once in the evening.
Placebo
Topical application, 7 sprays (approximately 1 mL)/time, in the target area of the scalp (8 cm × 8 cm),starting from the center of the affected area, and massage with hands for 3-5 min. This dose is used regardless of the size of the affected area. It should be used when hair and scalp are completely dry. Wash hands after use. The control product will be administered in the evening once daily for QD dose groups, and once in the morning and once in the evening for the BID dose groups.
Peking University First Hospital, Beijing
Peking University People's Hospital, Beijing
Dermatology Hospital of Southern Medical University, Guangzhou
Guangdong Provincial People's Hospital, Guangzhou
Affiliated Hospital of Jiangsu University, Zhenjiang
Huashan Hospital, Shanghai
Shanghai Dermatology Hospital, Shanghai
Tianjin Medical University General Hospital, Tianjin
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Suzhou Kintor Pharmaceutical Inc,
INDUSTRY